New treatment approved for deadly blood cancer
The FDA approved the anti-cancer drug Besponsa, or inotuzumab ozogamicin, to treat B-cell acute lymphoblastic leukemia.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Health | Leukemia